Literature DB >> 28291165

Preoperative Treatment With FOLFIRINOX and Successful Resection for a Patient With Mixed Acinar-Endocrine Carcinoma of the Pancreas.

Motokazu Sugimoto1, O Joe Hines, David W Dawson, V Raman Muthusamy, Howard A Reber, Timothy R Donahue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28291165      PMCID： PMC5354082          DOI： 10.1097/MPA.0000000000000802

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  4 in total

1.  Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma.

Authors:  Nobuyuki Ohike; Markus Kosmahl; Günter Klöppel
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

2.  Pancreatic acinar cell carcinoma with bilateral ovarian metastases, panniculitis and polyarthritis treated with FOLFIRINOX chemotherapy regimen. A case report and review of the literature.

Authors:  Hector R Callata-Carhuapoma; Esperanza Pato Cour; Beatriz Garcia-Paredes; Ramiro Mendez Fernandez; Maria Luisa Mendoza Fernandez; Aranzazu Manzano Fernandez; Carlos Aguado De La Rosa; Miguel J Sotelo Lezama; Santiago Cabezas-Camarero; Javier Sastre Varela
Journal:  Pancreatology       Date:  2015-04-24       Impact factor: 3.996

3.  Mixed acinar-endocrine carcinoma of the pancreas: new clinical and pathological features in a contemporary series.

Authors:  Run Yu; Lily Jih; Jing Zhai; Nicholas N Nissen; Steven Colquhoun; Edward Wolin; Deepti Dhall
Journal:  Pancreas       Date:  2013-04       Impact factor: 3.327

4.  Mixed acinar-endocrine carcinoma of pancreas: A case report and brief review of the literature.

Authors:  Zhenzhen Liu; Chengyong Dong; Chengye Wang; Qinlong Liu; Deguang Sun; Liming Wang
Journal:  Onco Targets Ther       Date:  2015-07-03       Impact factor: 4.147
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.